Krilogy Financial’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.69M | Buy |
40,659
+499
| +1% | +$57.6K | 0.15% | 116 |
|
|
2025
Q4 | $4.31M | Buy |
40,160
+3,016
| +8% | +$283K | 0.15% | 118 |
|
|
2025
Q3 | $3.13M | Buy |
37,144
+21,122
| +132% | +$1.74M | 0.12% | 139 |
|
|
2025
Q2 | $1.27M | Buy |
+16,022
| New | +$1.27M | 0.07% | 167 |
|
|
2023
Q2 | – | Sell |
-7,729
| Closed | -$822K | – | 323 |
|
|
2023
Q1 | $822K | Sell |
7,729
-844
| -10% | -$91.1K | 0.07% | 204 |
|
|
2022
Q4 | $951K | Buy |
8,573
+335
| +4% | +$34.2K | 0.09% | 171 |
|
|
2022
Q3 | $709K | Buy |
8,238
+539
| +7% | +$48.1K | 0.08% | 157 |
|
|
2022
Q2 | $702K | Sell |
7,699
-7,607
| -50% | -$674K | 0.08% | 167 |
|
|
2022
Q1 | $1.26M | Sell |
15,306
-8,154
| -35% | -$643K | 0.13% | 111 |
|
|
2021
Q4 | $1.8M | Buy |
23,460
+2,473
| +12% | +$197K | 0.18% | 83 |
|
|
2021
Q3 | $1.58M | Buy |
20,987
+514
| +3% | +$39.1K | 0.16% | 94 |
|
|
2021
Q2 | $1.59M | Buy |
20,473
+22
| +0.1% | +$1.64K | 0.16% | 91 |
|
|
2021
Q1 | $1.5M | Buy |
20,451
+7,916
| +63% | +$584K | 0.16% | 89 |
|
|
2020
Q4 | $978K | Buy |
12,535
+197
| +2% | +$15.1K | 0.12% | 121 |
|
|
2020
Q3 | $977K | Sell |
12,338
-2,033
| -14% | -$159K | 0.14% | 99 |
|
|
2020
Q2 | $1.06M | Buy |
14,371
+2,132
| +17% | +$160K | 0.16% | 87 |
|
|
2020
Q1 | $899K | Buy |
12,239
+8,694
| +245% | +$683K | 0.17% | 79 |
|
|
2019
Q4 | $308K | Buy |
3,545
+314
| +10% | +$25.8K | 0.05% | 159 |
|
|
2019
Q3 | $260K | Buy |
3,231
+137
| +4% | +$11K | 0.05% | 158 |
|
|
2019
Q2 | $247K | Buy |
3,094
+517
| +20% | +$39.6K | 0.05% | 155 |
|
|
2019
Q1 | $205K | Buy |
+2,577
| New | +$193K | 0.04% | 166 |
|
|
2018
Q4 | – | Sell |
-3,070
| Closed | -$208K | – | 471 |
|
|
2018
Q3 | $208K | Buy |
+3,070
| New | +$196K | 0.05% | 140 |
|
|
2018
Q2 | – | Sell |
-2,214
| Closed | -$115K | – | 451 |
|
|
2018
Q1 | $115K | Buy |
2,214
+6
| +0.3% | +$324 | 0.03% | 213 |
|
|
2017
Q4 | $119K | Sell |
2,208
-1,117
| -34% | -$61.9K | 0.03% | 204 |
|
|
2017
Q3 | $203K | Buy |
3,325
+46
| +1% | +$2.79K | 0.05% | 165 |
|
|
2017
Q2 | $201K | Buy |
3,279
+11
| +0.3% | +$670 | 0.06% | 143 |
|
|
2017
Q1 | $184K | Hold |
3,268
| – | – | 0.06% | 138 |
|
|
2016
Q4 | $184K | Buy |
3,268
+803
| +33% | +$47K | 0.06% | 138 |
|
|
2016
Q3 | $147K | Sell |
2,465
-398
| -14% | -$23.3K | 0.05% | 160 |
|
|
2016
Q2 | $157K | Buy |
2,863
+911
| +47% | +$48.5K | 0.05% | 148 |
|
|
2016
Q1 | $99K | Sell |
1,952
-467
| -19% | -$22.9K | 0.04% | 180 |
|
|
2015
Q4 | $122K | Sell |
2,419
-17
| -0.7% | -$857 | 0.11% | 80 |
|
|
2015
Q3 | $115K | Buy |
+2,436
| New | +$129K | 0.05% | 124 |
|
Other funds holding MRK
VCM
VPM
Krilogy Financial's MRK Position: Q1 2026 in Review
Krilogy Financial increased its Merck (MRK) stake by 1.2% in Q1 2026, buying an estimated $57.6K and bringing the position to 40,659 shares worth $4.69M. The position accounts for 0.15% of the portfolio, ranked #116.
Krilogy Financial first reported a position in MRK in Q3 2015 and has held it in 33 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Krilogy Financial held 40,659 shares of Merck worth $4.69M as of Q1 2026.
- Krilogy Financial bought 499 Merck shares in Q1 2026, an estimated $57.6K.
- Merck made up 0.15% of Krilogy Financial's portfolio in Q1 2026, its #116 holding.
- Krilogy Financial first reported a position in Merck in Q3 2015 and has held it in 33 quarters since.
- 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Krilogy Financial's 13F filing for Q1 2026, filed 17 Apr 2026.